The Huatai-PB Hang Seng Invt Drug ETF seeks to replicate as closely as possible the price and yield performance of the Hang Seng Innovative Drug Index by investing in a portfolio comprised primarily of Chinese companies
The Huatai-PB Hang Seng Invt Drug ETF (CNY) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in China. The Huatai-PineBridge Fund Management fund’s base currency is CNY and the share class was registered 16.12.2024 with unique ISIN - CNE100006GB7. Main exchange is Shanghai SE and ticker symbol is 520500. The total expense ratio is 0.6%. The Huatai-PB Hang Seng Invt Drug ETF (CNY) pays dividends 1 time(s) per year.